S. Chellappan

The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.

P. Dent, S. Grant, L. Cartee, 2001, Cancer research.

Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).

A. Saunders, S. Grant, S. Chellappan, 1998, Differentiation; research in biological diversity.

Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60)

S. Grant, S. Chellappan, P. Fisher, 1997, Leukemia.

Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.

J. Nevins, S. Chellappan, L. Jakoi, 1993, The EMBO journal.

Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.

P. Fisher, A. Giordano, S. Chellappan, 1998, Current topics in microbiology and immunology.

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.

J. Nevins, S. Chellappan, S. Chellappan, 1992, Genes & development.

Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.

J. Nevins, P. Howley, K. Munger, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Cloning and characterization of human DP2, a novel dimerization partner of E2F.

S. Chellappan, S. Chellappan, Y. Zhang, 1995, Oncogene.

v-Abl activates c-myc transcription through the E2F site

A. Patel, K. Calame, S. Chellappan, 1995, Molecular and cellular biology.

E2F transcription factor is a target for the RB protein and the cyclin A protein.

J. Nevins, T. Hunter, S. Chellappan, 1991, Cold Spring Harbor symposia on quantitative biology.